Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Cited In for PubMed (Select 8017890)


Relapsing and progressive forms of multiple sclerosis: insights from pathology.

Dutta R, Trapp BD.

Curr Opin Neurol. 2014 Jun;27(3):271-8. doi: 10.1097/WCO.0000000000000094. Review.


XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis.

Du S, Itoh N, Askarinam S, Hill H, Arnold AP, Voskuhl RR.

Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2806-11. doi: 10.1073/pnas.1307091111. Epub 2014 Feb 3.


Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.

Achtnichts L, Gonen O, Rigotti DJ, Babb JS, Naegelin Y, Penner IK, Bendfeldt K, Hirsch J, Amann M, Kappos L, Gass A.

Eur J Radiol. 2013 Dec;82(12):e848-52. doi: 10.1016/j.ejrad.2013.08.037. Epub 2013 Sep 4.


Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.

Dutta R, Chomyk AM, Chang A, Ribaudo MV, Deckard SA, Doud MK, Edberg DD, Bai B, Li M, Baranzini SE, Fox RJ, Staugaitis SM, Macklin WB, Trapp BD.

Ann Neurol. 2013 May;73(5):637-45. doi: 10.1002/ana.23860. Epub 2013 Apr 17.


Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity.

Raimundo K, Tian H, Zhou H, Zhang X, Kahler KH, Agashivala N, Kim E.

BMC Health Serv Res. 2013 Apr 8;13:131. doi: 10.1186/1472-6963-13-131.


Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?

Jalilian B, Einarsson HB, Vorup-Jensen T.

Int J Mol Sci. 2012 Nov 9;13(11):14579-605. doi: 10.3390/ijms131114579. Review.


Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment.

Rigotti DJ, Gass A, Achtnichts L, Inglese M, Babb JS, Naegelin Y, Hirsch J, Amann M, Kappos L, Gonen O.

Mult Scler. 2012 Jan;18(1):98-107. doi: 10.1177/1352458511415142. Epub 2011 Sep 15.


Internet portal use in an academic multiple sclerosis center.

Nielsen AS, Halamka JD, Kinkel RP.

J Am Med Inform Assoc. 2012 Jan-Feb;19(1):128-33. doi: 10.1136/amiajnl-2011-000177. Epub 2011 May 12.


Quantitative measures detect sensory and motor impairments in multiple sclerosis.

Newsome SD, Wang JI, Kang JY, Calabresi PA, Zackowski KM.

J Neurol Sci. 2011 Jun 15;305(1-2):103-11. doi: 10.1016/j.jns.2011.03.003. Epub 2011 Apr 1.


Sex differences in autoimmune diseases.

Voskuhl R.

Biol Sex Differ. 2011 Jan 4;2(1):1. doi: 10.1186/2042-6410-2-1.


Gene expression profiling in multiple sclerosis brain.

Dutta R, Trapp BD.

Neurobiol Dis. 2012 Jan;45(1):108-14. doi: 10.1016/j.nbd.2010.12.003. Epub 2010 Dec 13. Review.


Global N-acetylaspartate declines even in benign multiple sclerosis.

Rigotti DJ, Gonen O, Grossman RI, Babb JS, Falini A, Benedetti B, Filippi M.

AJNR Am J Neuroradiol. 2011 Jan;32(1):204-9. doi: 10.3174/ajnr.A2254. Epub 2010 Oct 21.


Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Dutta R, Trapp BD.

Prog Neurobiol. 2011 Jan;93(1):1-12. doi: 10.1016/j.pneurobio.2010.09.005. Epub 2010 Oct 12. Review.


Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.

Kirov II, Liu S, Fleysher R, Fleysher L, Babb JS, Herbert J, Gonen O.

Radiology. 2010 Mar;254(3):858-66. doi: 10.1148/radiol.09091015.


Estrogen and testosterone therapies in multiple sclerosis.

Gold SM, Voskuhl RR.

Prog Brain Res. 2009;175:239-51. doi: 10.1016/S0079-6123(09)17516-7. Review.


Perceived needs and satisfaction with care in people with multiple sclerosis: a two-year prospective study.

Ytterberg C, Johansson S, Gottberg K, Holmqvist LW, von Koch L.

BMC Neurol. 2008 Sep 29;8:36. doi: 10.1186/1471-2377-8-36.


Gene expression studies in multiple sclerosis.

Tajouri L, Fernandez F, Griffiths LR.

Curr Genomics. 2007 May;8(3):181-9.


Multiple sclerosis.

Hafler DA.

J Clin Invest. 2004 Mar;113(6):788-94. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk